FTO rs6438552: Understanding Your Genetic Variant
The rs6438552 variant is a common genetic change located within the FTO gene, which has been extensively studied for its role in human metabolism. It is statistically associated with variations in body mass index (BMI) and is considered a marker of interest in obesity-related research.
What each genotype means
Potential for increased BMI
Research indicates that this genotype is associated with a slightly higher body mass index and increased risk for obesity compared to the GG genotype. These associations are statistical observations across large populations and do not determine an individual's personal health outcome, as weight is influenced by a complex interplay of genetics, lifestyle, and environment.
This genotype is common, though its exact prevalence varies significantly across different ancestral groups.
Average risk profile
Individuals with this genotype generally show intermediate statistical associations with body mass index compared to those with the AA or GG genotypes. Because this variant is just one of many genetic factors that contribute to body weight, this result should be viewed in the context of overall lifestyle and health history.
As a heterozygous genotype, this is frequently observed in many global populations.
Baseline risk profile
In the context of this specific variant, this genotype is generally associated with a baseline or lower statistical risk for elevated body mass index compared to the A-allele. It is important to remember that genetic associations with complex traits like obesity are multifactorial, and this genotype does not preclude weight-related health concerns.
This genotype is common in many populations, representing a frequent genetic state for this locus.
What is rs6438552?
The rs6438552 variant is a single-nucleotide polymorphism (SNP) located within the FTO (fat mass and obesity-associated) gene. SNPs are the most common type of genetic variation among people, representing a difference in a single DNA building block, or nucleotide. This specific variant sits in a region of the genome that has been a primary focus of large-scale genome-wide association studies (GWAS) since the mid-2000s. Researchers identify these variants by comparing the DNA of large groups of people to see if certain genetic patterns appear more frequently in individuals with specific physical traits, such as a higher or lower body mass index. Because rs6438552 is located in a non-coding region of the FTO gene, it is thought to influence how the gene is regulated rather than changing the structure of the protein the gene produces.
The Role of the FTO Gene
The FTO gene provides instructions for making an enzyme that acts as a nucleic acid demethylase, which plays a role in regulating gene expression by modifying RNA. While the exact biological mechanisms are complex, research suggests that the FTO gene is highly expressed in the brain, particularly in areas involved in energy balance and appetite regulation. Studies have shown that variants in this gene can influence mitochondrial thermogenesis—the process by which cells generate heat—in fat precursor cells. By affecting how these cells function, the FTO gene may influence how the body stores energy and manages fat mass. It is important to note that the FTO gene does not act in isolation; it is part of a complex network of genetic and environmental factors that collectively influence human metabolism and body composition.
Research and Evidence Strength
The association between FTO variants and body mass index is one of the most replicated findings in modern human genetics. Since the initial discovery in 2007, numerous studies have confirmed that certain variants in this region are linked to an increased risk of higher BMI and obesity in both children and adults. The evidence for the FTO region as a whole is considered strong, though the specific effect size of any single SNP like rs6438552 can be modest. It is crucial to understand that these associations are statistical, not deterministic. Having a particular genotype does not guarantee a specific body weight, as lifestyle factors such as diet, physical activity, and socioeconomic environment play significant roles. Current research continues to investigate how these genetic markers interact with environmental triggers to influence health outcomes across diverse populations.
What You Can Do With This Information
Genetic information regarding variants like rs6438552 is primarily intended for educational purposes and to help researchers understand the biological basis of human traits. Because body weight is a complex trait influenced by many genes and environmental factors, this SNP cannot be used to predict an individual's health or weight with certainty. If you are concerned about your weight or metabolic health, it is best to consult with a healthcare professional or a registered dietitian. They can provide personalized guidance based on your medical history, lifestyle, and clinical measurements. Avoid making health decisions based solely on genetic reports, as they do not account for the full picture of your health. Instead, use this information as a starting point for a conversation with your doctor about evidence-based strategies for maintaining a healthy lifestyle.
How common is this variant?
The rs6438552 variant is considered a common SNP, with its alleles appearing at varying frequencies across different global ancestral populations.
Frequently asked questions
Does having this variant mean I will be obese?
No. Genetic variants like rs6438552 are associated with statistical trends in populations, not individual outcomes. Many factors, including diet, exercise, and environment, have a much larger impact on body weight than any single genetic variant.
Can I change my genes if I have a risk-associated variant?
You cannot change your DNA sequence. However, research suggests that healthy lifestyle choices, such as regular physical activity and a balanced diet, can help mitigate the influence of genetic predispositions related to body weight.
Is this variant used for medical diagnosis?
No. This variant is used in research to understand the biology of metabolism and obesity. It is not used in clinical settings to diagnose obesity or to predict an individual's future health.
Where can I learn more about my own genetic data?
If you have received results from a direct-to-consumer genetic test, you can discuss them with a genetic counselor or your primary care physician. They can help you interpret the information in the context of your overall health.
Sources & further reading
Educational information only, last refreshed 10/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs6438552?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FTO
This variant is strongly associated with increased body mass index and obesity risk.
Variant in FTO associated with body mass index and obesity-related traits; evidence for sleep apnea is indirect via BMI.
Intronic regulatory variant in the FTO/IRX3 cluster strongly linked to elevated BMI, obesity susceptibility, and metabolic dysregulation.
Intronic SNP conferring a distinct preference for morning chronotype ('early bird' vs 'night owl') independently of metabolic phenotypes.
Intronic variant within the FTO locus, showing replicated association with body mass index and obesity risk.
Commonly associated with body mass index (BMI) and obesity risk, though sometimes misattributed in consumer genomics to facial morphology.